Our goal is to provide the highest level of expertise and to treat every patient with the same intensity and care we ...
Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results